CHADDS FORD, Pa., July 18, 2012 /PRNewswire-FirstCall/ -- Endo Health Solutions (Nasdaq: ENDP) today announced the appointment of Camille Farhat to President of American Medical Systems (AMS), a wholly owned subsidiary of Endo Health Solutions. AMS, based in Minnetonka, Minn., is a leader in the supply of medical devices and procedures to treat incontinence, erectile dysfunction, benign prostatic hyperplasia (BPH) and other pelvic disorders for men and women.
Prior to joining AMS, Mr. Farhat served in a variety of senior leadership positions within the healthcare industry; most recently as General Manager of Baxter Pharmaceuticals and Technologies. As General Manager, Mr. Farhat significantly enhanced the performance and improved the operating efficiency of the business. During his time at Baxter, he also held the role of General Manager for Baxter Global Infusion Systems. Before that, Mr. Farhat provided executive leadership at Medtronic, including roles in Business Development, as well as Global General Manager, Gastroenterology and Urology. In addition, he held a variety of positions at GE Healthcare, including roles as a Global General Manager of the Computed Tomography Business. He also held leadership positions in strategic planning and global sourcing at General Electric.
“We are thrilled to have someone of Camille’s experience and impressive track record join us to lead the AMS business,” said Dave Holveck, president and CEO of Endo Health Solutions. “We are at a pivotal moment in implementing our strategy and we believe that a proven leader like Camille will allow us to enhance the growth trajectory of AMS. Camille has demonstrated the ability to lead global businesses that are complex, highly competitive, and transformational. We believe that Camille also has the right operational experience, communication skills and leadership attributes to deliver improved execution and efficiency, new innovation as well as enhanced financial performance.”
About Endo
Endo Health Solutions Inc. (Endo) is a U.S.-based diversified healthcare company that is redefining healthcare value by finding solutions for the unmet needs of patients along care pathways for pain management, pelvic health, urology, endocrinology and oncology. Through our operating companies: AMS, Endo Pharmaceuticals, HealthTronics and Qualitest, Endo is dedicated to improving care through a combination of branded products, generics, devices, technology and services that creates maximum value for patients, providers and payers alike. Learn more at www.endo.com.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements including words such as “believes,” “expects,” “anticipates,” “intends,” “estimates,” “plan,” “will,” “may,” “look forward,” “intend,” “guidance,” “future” or similar expressions are forward-looking statements. Because these statements reflect our current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors, as more fully described under the caption “Risk Factors” in our Form 10-K, Form 10-Q and Form 8-K filings with the Securities and Exchange Commission and as otherwise enumerated herein or therein, could affect our future financial results and could cause our actual results to differ materially from those expressed in forward-looking statements contained in our Annual Report on Form 10-K. The forward-looking statements in this press release are qualified by these risk factors. These are factors that, individually or in the aggregate, could cause our actual results to differ materially from expected and historical results. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.
SOURCE Endo Health Solutions Inc.
